UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.

Konig, MF; Kim, AH; Scheetz, MH; Graef, ER; Liew, JW; Simard, J; Machado, PM; ... COVID-19 Global Rheumatology Alliance; + view all (2020) Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19. Annals of the Rheumatic Diseases 10.1136/annrheumdis-2020-217690. (In press). Green open access

[thumbnail of HCQ Paper.pdf]
Preview
 Text
HCQ Paper.pdf - Accepted Version
Download (155kB) | Preview
Type: Article
Title: Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1136/annrheumdis-2020-217690
Publisher version: http://dx.doi.org/10.1136/annrheumdis-2020-217690
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Department of Neuromuscular Diseases
URI: https://discovery.ucl.ac.uk/id/eprint/10098285
Downloads since deposit
72Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item